TMC Life Sciences Bhd Market Cap ($183.68 Million)
Market Cap & Net Worth: TMC Life Sciences Bhd (0101)
TMC Life Sciences Bhd market cap. TMC Life Sciences Bhd (KLSE:0101) has a market capitalization of $183.68 Million (RM731.59 Million) as of October 31, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #16669 globally and #224 in its home market, demonstrating a 1.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TMC Life Sciences Bhd's stock price RM0.42 by its total outstanding shares 1741882393 (1.74 Billion).
TMC Life Sciences Bhd Market Cap History (2015–2026)
TMC Life Sciences Bhd market cap history from 2015 to 2026. Data shows change from $302.19 Million to $183.68 Million (-2.39% CAGR). Check 0101 share price today for real-time trading data and today's change.
TMC Life Sciences Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TMC Life Sciences Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see TMC Life Sciences Bhd cash conversion from operations for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.47x
TMC Life Sciences Bhd's market cap is 0.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.57x
TMC Life Sciences Bhd's market cap is 10.57 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $364.51 Million | $151.71 Million | $26.03 Million | 2.40x | 14.00x |
| 2018 | $311.86 Million | $169.04 Million | $27.80 Million | 1.84x | 11.22x |
| 2019 | $269.83 Million | $194.98 Million | $20.92 Million | 1.38x | 12.90x |
| 2020 | $284.44 Million | $184.09 Million | $15.93 Million | 1.55x | 17.86x |
| 2021 | $229.34 Million | $201.02 Million | $20.25 Million | 1.14x | 11.32x |
| 2022 | $273.90 Million | $243.77 Million | $41.39 Million | 1.12x | 6.62x |
| 2023 | $312.69 Million | $311.44 Million | $39.26 Million | 1.00x | 7.97x |
| 2024 | $218.66 Million | $346.42 Million | $40.65 Million | 0.63x | 5.38x |
| 2025 | $196.80 Million | $345.54 Million | $3.61 Million | 0.57x | 54.58x |
| 2026 | $183.68 Million | $393.03 Million | $17.38 Million | 0.47x | 10.57x |
Competitor Companies of 0101 by Market Capitalization
Companies near TMC Life Sciences Bhd in the global market cap rankings as of October 31, 2026. See TMC Life Sciences Bhd balance sheet quality to understand what proportion of total assets are financed by equity.
Key companies related to TMC Life Sciences Bhd by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of TMC Life Sciences Bhd (2015–2026)
Market capitalization of TMC Life Sciences Bhd from 2015 to today. Between 2015 and today, TMC Life Sciences Bhd's market cap moved from $302.19 Million to $ 183.68 Million, with a yearly change of -2.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM183.68 Million | -6.67% |
| 2025 | RM196.80 Million | -10.00% |
| 2024 | RM218.66 Million | -30.07% |
| 2023 | RM312.69 Million | +14.16% |
| 2022 | RM273.90 Million | +19.43% |
| 2021 | RM229.34 Million | -19.37% |
| 2020 | RM284.44 Million | +5.41% |
| 2019 | RM269.83 Million | -13.48% |
| 2018 | RM311.86 Million | -14.45% |
| 2017 | RM364.51 Million | -10.33% |
| 2016 | RM406.50 Million | +34.52% |
| 2015 | RM302.19 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of TMC Life Sciences Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $183.68 Million USD |
| MoneyControl | $183.68 Million USD |
| MarketWatch | $183.68 Million USD |
| marketcap.company | $183.68 Million USD |
| Reuters | $183.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more